Clinical Trial Update: High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network [NA]

View source ↗

Summary

A clinical trial investigating high-throughput omics to identify biomarkers in relapsing Acute Disseminated Encephalomyelitis and autoimmune encephalitis; recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Encephalitis
• Disseminated Encephalomyelitis

Snippet

Sponsor: University Hospital, Angers | Conditions: Acute Disseminated Encephalomyelitis, Encephalitis Autoimmune | NA | Status: RECRUITING